Trademarkia Logo

Canada

C$
MORPHOMER
SEARCHED

on 30 Jul 2024

Last Applicant/ Owned by

AC IMMUNE SA

EPFL Innovation ParkBuilding BCH-1015 Lausanne,

CH

Serial Number

1987267 filed on 26th Sept 2019

Correspondent Address

GOWLING WLG (CANADA) LLP

1 PLACE VILLE MARIE37TH FLOOR/37E ETAGEMONTREAL

QUÉBEC

CA

H3B3P4

MORPHOMER

Trademark usage description

chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements; chemical, biochemi Read More

Classification Information


Class [001]
Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements; chemical, biochemical, biological and biotechnological preparations; protein, fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; small molecules; molecular libraries; small molecule library; antibody library; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes [excluding medical purposes] or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use.


Classification kind code

11

Class [005]
Pharmaceuticals, medical and veterinary preparations; diagnostic preparations and materials; diagnostic tools, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds; chemical preparations for medical purposes; chemico-pharmaceutical preparation for medical purposes; antibodies, antibody fragments and antibody derivatives for medical purposes; small molecule compounds for medical purposes; PET-Imaging; companion compound; biomarkers; vaccines; antigenic peptide; protein or fragment; diagnostic reagents for medical purposes; diagnostic antibodies.


Classification kind code

11

Class [009]
Electrical, scientific and teaching apparatus and software


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [038]
Telecommunications


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Scientific and technological services and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules; biological research services; chemical research services; medical research services; clinical trials; laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; screening and selection of pharmaceutical active substances from biological and biotechnological preparations; Assay development; vaccine, antibody engineering.


Classification kind code

11

Mark Details


Serial Number

1987267

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 30th Jul 2024
Search Recorded
Submitted for opposition 20
on 30th Jul 2024
Examiner's First Report
Submitted for opposition 287
on 19th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 7th Oct 2019
Formalized
Submitted for opposition 1
on 27th Sept 2019
Created
Submitted for opposition 30
on 26th Sept 2019
Filed